Galmed Pharmaceuticals (EOCN) EBIT (2013 - 2024)
Galmed Pharmaceuticals (EOCN) reported EBIT of $1.82 million for FY2025, down 17.2% from $2.2 million in FY2024.
Analysis
Galmed Pharmaceuticals (EOCN) EBIT (2013 - 2024) Analysis & Trends
Dating back to FY2011, Galmed Pharmaceuticals' EBIT record includes 15 years.
- EBIT has declined for four consecutive years, with a five-year compound annual growth rate of -43.0% (FY2020 to FY2025).
- The FY2025 figure ranks as the lowest annual EBIT since FY2011.
- According to Business Quant data, EBIT came in at $2.2 million in FY2024 (-70.6%), $7.49 million in FY2023 (-57.6%), $17.65 million in FY2022 (-46.3%) and $32.88 million in FY2021 (+8.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 653,000.00 |
| Jun 30, 2023 | 573,000.00 |
| Mar 31, 2023 | -588,000.00 |
| Jun 30, 2022 | 286,000.00 |
| Mar 31, 2022 | -250,000.00 |
| Jun 30, 2020 | 5.82 Mn |
| Mar 31, 2020 | 6.46 Mn |
| Dec 31, 2019 | 8.29 Mn |
| Sep 30, 2019 | 4.51 Mn |
| Jun 30, 2019 | 4.70 Mn |
| Mar 31, 2019 | 4.04 Mn |
| Dec 31, 2018 | 4.20 Mn |
| Sep 30, 2018 | 1.18 Mn |
| Jun 30, 2018 | 2.60 Mn |
| Mar 31, 2018 | 2.56 Mn |
| Dec 31, 2017 | 3.64 Mn |
| Sep 30, 2017 | 2.76 Mn |
| Jun 30, 2017 | 2.68 Mn |
| Mar 31, 2017 | 3.26 Mn |
| Dec 31, 2016 | 4.75 Mn |
API Access
Galmed Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=EOCN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();